公开(公告)号：US20210254168A1

公开(公告)日：2021-08-19

申请号：US16972984

申请日：2019-06-10

Applicant: ACADEMIA SINICA

Inventor： Pei-Wen HSIAO ,  Chin-Hsien TSAI ,  Sheue-Fen TZENG ,  Shih-Chuan HSIEH ,  Ming-Shyue LEE

IPC: C12Q1/6886 ,  G01N33/574

Abstract: The present invention relates to biomarkers, methods and assay kits for predicting prognosis and/or monitoring progression of prostate cancer. The biomarkers include a glycosyltransferases [core 1 beta-3-galactosyltransferase (C1GALT1) and/or ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1)] gene product, its saccharide substrate/product, and/or a galectin-4 gene product.